Suchergebnisse - "Tondini, Carlo"

PubPharm (142)

51

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

enthalten in: Human mutation | 2019

von Laitman, Y. | Friebel, T. | Yannoukakos, D. | +33

52

Italian Cohort of the Nivolumab EAP in Squamous NSCLC : Efficacy and Safety in Patients With CNS Metastases

enthalten in: Anticancer research | 2019

von Cortinovis, D. | Chiari, R. | Catino, A. | +19

ErratumIn: Anticancer Res. 2020 Feb;40(2):1183. - PMID 32014978

53

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

enthalten in: Breast cancer research : BCR | 2019

von Rossi, L. | Biagioni, C. | McCartney, A. | +17

54

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

enthalten in: Breast cancer research | 2019

von Rossi, L. | Biagioni, C. | McCartney, A. | +17

55

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

enthalten in: Breast cancer research | 2019

von Rossi, L. | Biagioni, C. | McCartney, A. | +17

56

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Bachelot, T. | Ciruelos, E. | Schneeweiss, A. | +111

CommentIn: Ann Oncol. 2019 May 1;30(5):665-667. - PMID 30888412

57

Cobimetinib in malignant melanoma : how to MEK an impact on long-term survival

enthalten in: Future oncology (London, England) | 2019

von Indini, A. | Tondini, C. | Mandalà, M.

58

Homologous recombination DNA repair defects in PALB2-associated breast cancers

enthalten in: NPJ breast cancer | 2019

von Li, A. | Geyer, F. | Blecua, P. | +132

ErratumIn: NPJ Breast Cancer. 2019 Nov 19;5:44. - PMID 31754629

59

Erratum : Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers

enthalten in: NPJ breast cancer | 2019

von Li, A. | Geyer, F. | Blecua, P. | +132

ErratumFor: NPJ Breast Cancer. 2019 Aug 8;5:23. - PMID 31428676

60

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness

enthalten in: Journal of the American Academy of Dermatology | 2019

von Ribero, S. | Galli, F. | Osella-Abate, S. | +19